JENNIFER ROGGY: Open Payments
NPI 1578714895 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 12 payments from 9 companies in 2025. Trend: 2023 $5,658 · 2024 $312 · 2025 $744
Food & beverage: $644Education: $100
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $132 |
| Daiichi Sankyo Inc. | 1 | $118 |
| PharmaEssentia USA Corporation | 1 | $112 |
| SEAGEN INC. | 1 | $100 |
| Myriad Genetic Laboratories, Inc. | 1 | $96 |
| Amgen Inc. | 1 | $88 |
| ABBVIE INC. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Trodelvy, Enhertu, BESREMI, MYRISK, IMDELLTRA (AMG757), EPKINLY, KEYTRUDA, OJJAARA.
Industry payments across MO — which companies pay providers there.
